Drugs / NCX-1000
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00414869 | Nov 2005 → Feb 2007 | portal hypertension | Forest Laboratories | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NCX-1000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00414869 ↗ |
| Modality | Small molecule | — CHEMBL396290 ↗ |
| Route | Oral | “PO x 16 days” NCT00414869 ↗ |